OncoSec Medical Inc ONCS Shares traded higher on Monday after the company announced it is seeking to withdraw its registration statement.

What happened: OncoSec Medical has filed a petition with the SEC to withdraw its registration statement filed on March 28.

The March filing included an expected offering of more than 11 million shares and over 11 million warrants.

“The company is requesting withdrawal of the registration statement because it has elected not to proceed with the offering contemplated,” the company said in the new filing.

OncoSec confirmed that no securities were sold in the previously announced offering.

OncoSec is a biotechnology company focused on the development of intratumoral immunotherapies to stimulate the body’s immune system to attack and fight cancer.

From last week: OncoSec shares disappointing results from skin cancer combination therapy study and paves the way for neoadjuvant adjustment study

ONCS Price Promotion: OncoSec has a 52-week high of $25.74 and a 52-week low of 73 cents.

As of press time, the stock is up 48.1% to $1.67 Gasoline Pro.

Photo: Konstantin Kolosov from Pixabay.